The Willamette Health Council has partnered with Marion County Health and Human Services, Polk County Health Services, Salem Health, and WVP Health Authority to coordinate efforts to inform the local healthcare provider community about the availability of the nirsevimab (Beyfortus™) vaccine in the Marion-Polk region.
What is Beyfortus™? Beyfortus™ is a new immunization used to help prevent a serious lung disease caused by Respiratory Syncytial Virus (RSV) in:
- Newborns and babies under 8 months of age born during or entering their first RSV season.
- Except in rare circumstances, most infants younger than 8 months do not need Beyfortus if they were born 14 or more days after their mother got RSV vaccine.
- Children age 8 through 19 months who are at increased risk for severe RSV disease and entering their second RSV season.
For interim recommendations regarding the limited supply of Beyfortus, please visit the CDC website and review a recent health alert.
Toward improving regional access to nirsevimab, we have developed a Smartsheet tracker. Through this tracker, our aim is to facilitate direct communication among local clinics that need or have surplus supply of 50mg and 100mg doses of nirsevimab. We also aim to monitor regional vaccine administration activity to inform future vaccine coordination work. To gain access to the Smartsheet tracker, please email Mercedes Floyd at email@example.com.
For additional information, download our letter to local healthcare partners here.